Amanda Wagner

Amanda Wagner serves as the Chief Executive Officer of Immunitas Therapeutics, a role held since October 2019, and concurrently holds the position of Chief Business Officer at the National Alopecia Areata Foundation. Previous experience includes a tenure as Vice President of Corporate & Business Development at Q32 Bio Inc. and Vice President of Business Development & Product Strategy at Concert Pharmaceuticals, Inc. Educational qualifications include an MBA with highest honors from Simmons College and a BA in neuropsychology from Goucher College, where Amanda was recognized as a full tuition merit scholar. Additionally, Amanda has contributed to the field as a research assistant at McLean Hospital and has a strong foundation in sales account management from UpToDate, Inc.